Philadelphia Trust Co. reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s […]